Roche Holding Ag Stock Number Of Shares Shorted
| RHHBF Stock | USD 288.23 2.52 0.88% |
Roche Holding AG fundamentals help investors to digest information that contributes to Roche Holding's financial success or failures. It also enables traders to predict the movement of Roche OTC Stock. The fundamental analysis module provides a way to measure Roche Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roche Holding otc stock.
Roche |
Roche Holding AG OTC Stock Number Of Shares Shorted Analysis
Roche Holding's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Roche Holding AG has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—General (which currently averages 0.0) industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Roche Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roche Holding's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Roche Holding could also be used in its relative valuation, which is a method of valuing Roche Holding by comparing valuation metrics of similar companies.Roche Holding is currently under evaluation in number of shares shorted category among its peers.
Roche Fundamentals
| Return On Equity | 0.45 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 287.91 B | |||
| Shares Outstanding | 106.69 M | |||
| Shares Owned By Insiders | 75.31 % | |||
| Shares Owned By Institutions | 8.56 % | |||
| Price To Earning | 21.63 X | |||
| Price To Book | 11.61 X | |||
| Price To Sales | 4.11 X | |||
| Revenue | 62.8 B | |||
| Gross Profit | 47.83 B | |||
| EBITDA | 22.26 B | |||
| Net Income | 13.93 B | |||
| Cash And Equivalents | 6.81 B | |||
| Cash Per Share | 8.50 X | |||
| Total Debt | 16.08 B | |||
| Debt To Equity | 1.00 % | |||
| Current Ratio | 1.11 X | |||
| Book Value Per Share | 35.03 X | |||
| Cash Flow From Operations | 20.98 B | |||
| Earnings Per Share | 19.18 X | |||
| Price To Earnings To Growth | 4.18 X | |||
| Target Price | 423.65 | |||
| Number Of Employees | 103.61 K | |||
| Beta | 0.19 | |||
| Market Capitalization | 246.23 B | |||
| Total Asset | 92.32 B | |||
| Retained Earnings | 25.51 B | |||
| Working Capital | 2.16 B | |||
| Current Asset | 26.61 B | |||
| Current Liabilities | 24.46 B | |||
| Z Score | 9.0 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 3.23 % | |||
| Net Asset | 92.32 B | |||
| Last Dividend Paid | 9.5 |
About Roche Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roche Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roche Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roche Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Roche OTC Stock
Roche Holding financial ratios help investors to determine whether Roche OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Roche with respect to the benefits of owning Roche Holding security.